Mosaic Immunoengineering INC. (CPMV) — 8-K Filings

8-K Filings (7)

• Mosaic ImmunoEngineering Files 8-K — Jan 2, 2025 Risk: low
  Mosaic ImmunoEngineering, Inc. filed an 8-K report on January 2, 2025, detailing events as of December 31, 2024. The filing primarily concerns financial stateme
• Mosaic ImmunoEngineering Adds Biotech Veteran to Board — Jul 25, 2024 Risk: medium
  Mosaic ImmunoEngineering Inc. announced on July 23, 2024, the election of Dr. Jonathan Lim to its Board of Directors. Dr. Lim brings extensive experience in the
• Mosaic ImmunoEngineering Files 8-K: Board & Officer Changes — May 31, 2024 Risk: low
  Mosaic ImmunoEngineering, Inc. filed an 8-K on May 31, 2024, reporting changes in its board of directors and certain officers, along with updates to compensator
• Mosaic ImmunoEngineering Changes Auditors — May 21, 2024 Risk: low
  Mosaic ImmunoEngineering Inc. announced on May 21, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered pu
• BioNTech to Acquire Mosaic ImmunoEngineering — Apr 29, 2024 Risk: medium
  Mosaic ImmunoEngineering Inc. announced on April 26, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of BioNTech SE. The tr
• Mosaic ImmunoEngineering Announces Director Changes — Apr 19, 2024 Risk: low
  Mosaic ImmunoEngineering Inc. announced on April 17, 2024, the departure of Director Dr. David J. Earp and the appointment of Dr. Robert J. Valeri as a new dire
• Mosaic ImmunoEngineering Enters and Terminates Agreements — Mar 28, 2024 Risk: medium
  Mosaic ImmunoEngineering Inc. entered into a Material Definitive Agreement on March 22, 2024. The company also terminated a Material Definitive Agreement on the

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX